JINZHEN for Treatment of Mild to Moderate COVID-19
Public ClinicalTrials.gov record NCT05092503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/Ⅱ Randomized Controlled Proof-of-concept Study to Evaluate the Safety and Efficacy of JINZHEN Granules for Oral Solution in Participants With Mild to Moderate COVID-19
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
JINZHEN is a botanical drug that contains eight chemical constituents extracted from plant, mineral and animal origin raw materials. This study is to evaluate the safety and efficacy of JINZHEN Granules for Oral Solution compared to placebo for treatment of mild to moderate COVID-19 outpatients.
Study identification
- NCT ID
- NCT05092503
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 25, 2022
- Primary completion
- May 11, 2023
- Completion
- May 11, 2023
- Last update posted
- Mar 19, 2024
2022 – 2023
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clearview Medical Research LLC | Canyon Country | California | 91351 | — |
| Family First Medical Research Center | Hialeah Gardens | Florida | 33016 | — |
| LMG Research | Miami | Florida | 33016 | — |
| AA Medical Research Center | Flint | Michigan | 48504 | — |
| F. Gabriel LLC | Bayonne | New Jersey | 07002 | — |
| Carolina Institute for Clinical Research | Fayetteville | North Carolina | 28303 | — |
| Frontier Clinical Research LLC | Smithfield | Pennsylvania | 15478 | — |
| Piedmont Research Partners | Fort Mill | South Carolina | 29707 | — |
| SMS Clinical Research | Mesquite | Texas | 75149 | — |
| Frontier Clinical Research LLC | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05092503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2024 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05092503 live on ClinicalTrials.gov.